Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
New England Journal of Medicine · 05.12.2024 · 391 (22) · 2110-2122
DOI: 10.1056/nejmoa2407086 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 05.12.2024. Verfasst von Aditya Bardia und 19 weiteren Autor:innen. Beteiligte Einrichtung: From Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, and Massachusetts General Hospital, Boston, MA (A.B.); …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Antineoplastic Agents, Immunological, Breast Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 534-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: AstraZeneca and Daiichi Sankyo.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, and Massachusetts General Hospital, Boston, MA (A.B.); the Department of Medical Oncology, Fudan University Shanghai Cancer C…
ORCID-Profile: Joohyuk Sohn, Giuseppe Curigliano
Förderung
- AstraZeneca and Daiichi Sankyo
Zitieren
APA
Bardia, A., Hu, X., Dent, R., Yonemori, K., Barrios, C. H., O'Shaughnessy, J. A., Wildiers, H., Pierga, J. Y., Zhang, Q., Saura, C., Biganzoli, L., Sohn, J., Im, S. A., Lévy, C., Jacot, W., Begbie, N., Ke, J., Patel, G., Curigliano, G., & DESTINY-Breast06 Trial Investigators (2024). Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. New England Journal of Medicine, 391(22), 2110-2122. https://doi.org/10.1056/nejmoa2407086
Vancouver
Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, et al. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. New England Journal of Medicine. 2024;391(22):2110-2122. doi:10.1056/nejmoa2407086
BibTeX
@article{Bardia2024,
author = {Bardia, Aditya and Hu, Xichun and Dent, Rebecca and Yonemori, Kan and Barrios, Carlos H and O'Shaughnessy, Joyce A and Wildiers, Hans and Pierga, Jean-Yves and Zhang, Qingyuan and Saura, Cristina and Biganzoli, Laura and Sohn, Joohyuk and Im, Seock-Ah and Lévy, Christelle and Jacot, William and Begbie, Natasha and Ke, Jun and Patel, Gargi and Curigliano, Giuseppe and DESTINY-Breast06 Trial Investigators, DESTINY-Breast06 Trial Investigators},
title = {Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {22},
pages = {2110--2122},
doi = {10.1056/nejmoa2407086}
}
EUVIMED